HOUSE DOCKET, NO. 2449        FILED ON: 2/17/2021

HOUSE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 1143

 

The Commonwealth of Massachusetts

_________________

PRESENTED BY:

David Henry Argosky LeBoeuf

_________________

To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:

The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:

An Act relative to fair access for qualifying patients.

_______________

PETITION OF:

 

Name:

District/Address:

Date Added:

David Henry Argosky LeBoeuf

17th Worcester

2/17/2021

Vanna Howard

17th Middlesex

2/26/2021

Elizabeth A. Malia

11th Suffolk

3/15/2021

Lindsay N. Sabadosa

1st Hampshire

3/4/2021

James B. Eldridge

Middlesex and Worcester

4/25/2021


HOUSE DOCKET, NO. 2449        FILED ON: 2/17/2021

HOUSE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 1143

By Mr. LeBoeuf of Worcester, a petition (accompanied by bill, House, No. 1143) of David Henry Argosky LeBoeuf and others relative to eligibility for reimbursement by certain health plans.  Financial Services.

 

The Commonwealth of Massachusetts

 

_______________

In the One Hundred and Ninety-Second General Court
(2021-2022)

_______________

 

An Act relative to fair access for qualifying patients.

 

Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
 

SECTION 1. Notwithstanding any general or special law, a health care provider certifying a patient in accordance with Section 1 of Chapter 94I of the Massachusetts General Laws may be eligible for reimbursement for such certification by qualifying health plans regulated under Chapters 32A, 175, 176A, 176B and 176G.

SECTION 2. Health plans may include cannabis for medical use, as defined in Section 1 of Chapter 94I of the Massachusetts General Laws in their formulary, subject to its inclusion on Schedule II, Schedule III, Schedule IV, Schedule V, or Schedule VI of the Drug Control Program within the Department of Public Health.